Caption Management, LLC

Position in ASND — Ascendis Pharma A/S

CIK 1706766 OKLAHOMA CITY, OK

Back to ASND Full portfolio

Position in ASND

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

+$0 QoQ

Shares Held

Ownership

0.000%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2021

19 quarters on record

Common Shares in ASND Over Time

Shares Held

Position Value (USD)

Derivatives in ASND

reported options exposure · as of Mar 31, 2026

CallValue

$56,496,310

CallShares

247,000

PutValue

PutShares

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

Caption Management, LLC holds $195,300,170 across 69 Biotechnology names.

#	Ticker	Company	Shares	Value (USD)
1	CGON	CG Oncology, Inc.	378,480	$25,615,526
2	IMCR	Immunocore Holdings plc	661,786	$19,952,847
3	CYTK	Cytokinetics Inc	245,000	$16,147,950
4	ELVN	Enliven Therapeutics, Inc.	370,000	$14,504,000
5	SLNO	Soleno Therapeutics Inc	420,143	$14,066,387
6	CNTA	Centessa Pharmaceuticals plc	274,116	$10,887,887
7	CORT	Corcept Therapeutics Inc	260,000	$10,480,600
8	HRMY	Harmony Biosciences Holdings, Inc.	272,292	$7,626,898

All Filings in ASND

Export CSV

40 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$56,496,310	247,000	+141.0%	Call	Sole	2026-05-15
2025-12-31	$21,857,100	102,500	-55.4%	Put	Sole	2026-02-17
2025-12-31	$49,045,200	230,000	+117.8%	Call	Sole	2026-02-17
2025-09-30	$20,994,336	105,600	+608.7%	Call	Sole	2025-11-14
2025-09-30	$2,962,269	14,900	+129.3%	Put	Sole	2025-11-14
2025-06-30	$1,121,727	6,499	-67.5%	Shares	Sole	2025-08-14
2025-06-30	$3,452,000	20,000	-63.6%	Put	Sole	2025-08-14
2025-06-30	$9,493,000	55,000	+83.3%	Call	Sole	2025-08-14
2025-03-31	$4,675,800	30,000	+15.4%	Put	Sole	2025-05-15
2025-03-31	$4,052,360	26,000	-13.3%	Shares	Sole	2025-05-15
2024-12-31	$4,130,100	30,000	-33.9%	Put	Sole	2025-02-14
2024-12-31	$6,247,602	45,381	+39.6%	Shares	Sole	2025-02-14
2024-09-30	$4,852,575	32,500	+160.0%	Call	Sole	2024-11-14
2024-09-30	$1,866,375	12,500	+171.7%	Put	Sole	2024-11-14
2024-06-30	$627,348	4,600	-35.2%	Shares	Sole	2024-08-14
2024-06-30	$968,298	7,100	-85.8%	Put	Sole	2024-08-14
2024-03-31	$7,558,500	50,000	+430.4%	Put	Sole	2024-05-15
2024-03-31	$1,424,928	9,426	-63.7%	Shares	Sole	2024-05-15
2023-09-30	$2,434,640	26,000	-20.0%	Call	Sole	2023-11-14
2023-06-30	$2,900,625	32,500	-77.3%	Put	Sole	2023-08-14
2023-06-30	$12,780,600	143,200	-68.8%	Call	Sole	2023-08-14
2023-03-31	$49,278,312	459,600	+1738.4%	Call	Sole	2023-05-15
2023-03-31	$2,680,500	25,000	-84.3%	Put	Sole	2023-05-15
2022-12-31	$19,443,096	159,200	+536.8%	Call	Sole	2023-02-14
2022-12-31	$3,053,250	25,000	-96.1%	Put	Sole	2023-02-14
2022-09-30	$66,912,480	648,000	+2845.5%	Call	Sole	2022-11-14
2022-09-30	$2,271,720	22,000	-10.1%	Put	Sole	2022-11-14
2022-09-30	$2,526,978	24,472	-2.1%	Shares	Sole	2022-11-14
2022-03-31	$2,934,000	25,000	+575.5%	Put	Sole	2022-05-13
2022-03-31	$434,349	3,701	-81.5%	Shares	Sole	2022-05-13
2021-12-31	$2,690,600	20,000	0.0%	Put	Sole	2022-02-11
2021-12-31	$2,690,600	20,000	+257.1%	Call	Sole	2022-02-11
2021-12-31	$753,368	5,600	-72.0%	Shares	Sole	2022-02-11
2021-09-30	$3,187,800	20,000	0.0%	Call	Sole	2021-11-12
2021-09-30	$3,187,800	20,000	-88.3%	Put	Sole	2021-11-12
2021-06-30	$22,402,965	170,300	+1210.0%	Put	Sole	2021-08-16
2021-06-30	$1,710,150	13,000	-35.0%	Call	Sole	2021-08-16
2021-03-31	$2,577,600	20,000	-48.5%	Call	Sole	2021-05-17
2021-03-31	$5,000,544	38,800	+781.8%	Put	Sole	2021-05-17
2021-03-31	$567,072	4,400	—	Shares	Sole	2021-05-17
No filing history on record for this holder in this stock.